26 March 2020
Combining chemotherapy and immunotherapy to fight Glioblastoma Multiforme
Incysus Therapeutics, Inc., a Birmingham-based biopharmaceutical company, spin-off of the University of Alabama in Birmingham (UAB) has announced a phase…